MindMed Archives

Psychedelics News

MindMed

Press Releases

24 Aug 2020

MindMed Announces First-Ever Clinical Trial Combining MDMA and LSD

NEW YORK, Aug....

By Microdose

Press Releases

13 Aug 2020

Mind Medicine (MindMed) Inc. Announces Q2 2020 Financial Results

Reports Strong Cash Position of $24m USD To Execute Multiple Clinical Trials New York, – August 14, 2020 – Mind Medicine (MindMed) Inc....

By Microdose

Press Releases

12 Aug 2020

MindMed Expanding R&D in Europe, Appoints Dr. Miri Halperin Wernli As President

BASEL, Switzerland, Aug....

By Microdose

Press Releases

5 Aug 2020

MindMed Adds Psychedelic Assisted Therapy Expert Dr. Peter Gasser As Clinical Advisor For Project Lucy

Applauds Health Canada’s Approval Of Psilocybin Compassionate Access For Patients New York, NY, August 6, 2020 /PRNewswire/ — Mind Medicine (MindMed) Inc....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

26 Jun 2020

MindMed Building Diverse Pipeline and Leadership Position in Psychedelic Inspired Medicines Industry

MindMed Building Diverse Pipeline and Leadership Position in Psychedelic Inspired Medicines Industry MindMed Co-founders and Co-CEOs JR Rahn and Stephen Hurst to provide corporate update of activities and investor Q&A...

By Microdose

Press Releases

24 Jun 2020

MindMed Developing IP For Personalized Psychedelic Assisted Therapies

MindMed Developing IP For Personalized Psychedelic Assisted Therapies MindMed, in collaboration with the University Hospital Basel, has filed two separate patent applications for technologies to screen and optimize the dosing...

By Microdose

Press Releases

8 Jun 2020

Phase 2 Clinical Trial of LSD for “Suicide Headaches” Begins Treating Patients

Basel, Switzerland, June 8, 2020 /PRNewswire/ — Mind Medicine (MindMed) Inc....

By Microdose

Press Releases

4 Jun 2020

MindMed Launches Project Lucy Focused on LSD Experiential Therapy For Anxiety Disorders

MindMed Launches Project Lucy Focused on LSD Experiential Therapy ForAnxiety Disorders Targeting a Phase 2b psychedelic assisted therapy trial for the treatment of anxiety disorders NewYork, NY, June 4, 2020...

By Microdose

Press Releases

2 Jun 2020

MindMed’s Microdosing Division Further Expands Phase 2 Clinical Trial of Microdosing LSDFor Adult ADHD

MindMed’s Microdosing Division Further Expands Phase 2 Clinical Trial of Microdosing LSDFor Adult ADHD Adds Clinical Trial Site at University Hospital Basel and Appoints World Leading Psychedelics ResearcherDr....

By Microdose

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result